Genetic Association Reveals Protection against Recurrence of <italic toggle="yes">Clostridium difficile</italic> Infection with Bezlotoxumab Treatment

Genetic Association Reveals Protection against Recurrence of <italic toggle="yes">Clostridium difficile</italic> Infection with Bezlotoxumab Treatment

ABSTRACT Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B, indicated to prevent recurrence of C. difficile infection (rCDI) in high-risk adults receiving antibacterial treatment for CDI. An exploratory genome-wide association study investigated whether human genetic...

Full description

Saved in:
Bibliographic Details
Main Authors: Judong Shen, Devan V. Mehrotra, Mary Beth Dorr, Zhen Zeng, Junhua Li, Xun Xu, David Nickle, Emily R. Holzinger, Aparna Chhibber, Mark H. Wilcox, Rebecca L. Blanchard, Peter M. Shaw
Format: article
Language:EN
Published: American Society for Microbiology 2020
Subjects:
Clostridium difficile
antibacterials
bezlotoxumab
genomics
Microbiology
QR1-502
Online Access:https://doaj.org/article/adb561e16b8649aeaf98ce58ff6ef478
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/adb561e16b8649aeaf98ce58ff6ef478

Similar Items